Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/13/2018
CStone Initiates Two Pivotal Phase II Studies of Anti-PD-L1 mAb CS1001
6/13/2018
BMJ: Protecting the Accuracy of Clinical Trial Data in China
6/13/2018
Ascletis Receives Chinese Approval for Its Class 1 HCV Drug Danoprevir
6/13/2018
China to Conduct Training Programs for Indian Pharma Cos
6/12/2018
Chinese Government Launch Support Program for Biopharma CRO and CMO Se...
6/12/2018
CDE Solicits Feedbacks on Two Draft Technical Guidelines for Bioequiva...
6/12/2018
Hays: China's Middle Classes Are Growing in Numbers, Wealth and Influe...
6/12/2018
China Approves 4-Strain Flu Vaccine for 2018
6/12/2018
Suven Life Sciences Wins Patents in China and USA
6/11/2018
WuXi Biologics to Build a $60M Biologics Facility in the U.S.
6/10/2018
Will China's Promise to Boost Imports Benefit MNC Pharma Companies?
6/8/2018
Oncologie Commences Operations in Boston and Shanghai
6/8/2018
NMPA Issues 2017 Drug Inspection Report
6/8/2018
Recent Executive Moves
6/8/2018
Novo Nordisk Still Has Ample Room for Growth in China
6/7/2018
CNDA Suspends Import of Ambroxol Hydrochloride from India's Shilpa Med...
6/7/2018
CNDA Solicits Comments on 2nd Draft of the GMP Appendices for Narcotic...
6/6/2018
Hua Medicine Becomes Second Firm to Seek Hong Kong IPO under New Rules
6/6/2018
Guangdong Drug Regulator Sentenced Eight Years for Corruption
6/6/2018
CNDA Issues New Announcement (2018#30) for Clinical Data Self-Inspecti...
6/6/2018
Shanghai Bans Hospital Pharmacy Contract Management by Pharma Companie...
6/6/2018
CDE Solicits Feedbacks on Draft Dossier Requirements for Registration ...
6/6/2018
Chinese Military Adds 513 Drugs to Its Rationalized Medicine Drug List
6/6/2018
China Approves Indigenously-developed Long-acting Anti-HIV Drug
6/5/2018
Wize Pharma Signs China Distribution Deal for Dry Eye Drug LO2A
6/5/2018
The PD-1/PD-L1 Race in China
6/5/2018
MNC Pharma Cos Face Uncertainties of Chinese Data Transfer Rules
6/5/2018
NHC Issues Working Procedures for Developing the Rare Disease List
6/5/2018
CNDA Issues Notice to Strengthen Drug and Medical Device Regulation du...
6/5/2018
Xynmic Pharma Completes Series B Financing As It Opens R&D Cen...
Page:
266
/
720
Total number of articles:
21577
:
[First]
[<<]
[264]
[265]
[266]
[267]
[268]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit